Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
 
My Lists

Lygos

1249 Eighth Street
Berkeley, CA 94710
USA
Website Company Summary Management Team
Management

CEO: Eric Steen (7/31/2014)
Finance: Bryce Dille (3/31/2019) ; David Wang (05/31/2021)
Technology: Jeffrey Dietrich (4/30/2011) ; Nick Ohler (07/31/2020)
General Counsel/Legal: Photon Rao
Former Employees: Johan Van Walsem Kristy Hawkins
Board

Advisory board: Charles L Cooney (Massachusetts Institute of Technology Professor) Richard Bailey (Bio Architecture Lab) Jay Keasling (University of California, Berkeley Professor) Leonard Katz (Society for Industrial Microbiology and Biotechnology President)
Company

Business description: Lygos has created a full-stack biological engineering platform focused on organic acid specialty ingredients, health & wellness ingredients, including cannabinoids and bio-monomers. Lygos’ sustainable, bio-based chemicals replace expensive, environmentally degrading alternatives from traditional industrial suppliers, enabling customers to create better, safer products with value-added performance. For more information, visit www.lygos.com and follow us @LygosBiotech.
Capital

Rounds: 5
Recent Fundings: Apr 2022   Jan 2019
Capital raised: 193.5M
Last Round: 160.0M
Ownership: Private  
VCs include: First Round Capital IA Ventures FundersClub ;  Vast Ventures ;  Brainchild Holdings ;  OS Fund Fifty YearsY Combinator Continuity Fund
Corporate investors: LG Technology Ventures
Private equity: undisclosed investors
Other investors: United States Department of Energy

Last Tweets


 

Last Mentions


Overview
Record updated: Apr 2022
Sector: Biotech
Year Founded: 2010
Headcount: 26-50 as of Apr 2022
Rounds: 5
Recent Fundings: Apr 2022   Jan 2019
Capital Raised: 193.5M
Last Round: 160.0M
Ownership: Private